Redpin Therapeutics

Spotlight

EU approves Regeneron’s bispecific antibody following US rejection FDA approval of Regeneron’s myeloma drug delayed due to manufacturing issues Breaking News: Lecanemab approved in UK but unavailable on NHS First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1 Adcendo and Multitude target cancer resistance to ADCs in $1BN deal

Follow us

Most popular News

• 1 AstraZeneca invests $135M on expanding biologics facility in Sweden
• 2 European Commission grants orphan drug designation for rare disease gene therapy
• 3 Lilly to collaborate with Haya Therapeutics to develop drugs for metabolic conditions
• 4 Positive Phase II booster results for Lyme disease vaccine candidate
• 5 FDA grants expanded approval for Emergent Bio’s mpox vaccine

Webinars

Upcoming supplier webinars

• 17 Sep 2024 Tue Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Featured Suppliers

All

• Nicoya Lifesciences
• Thermo Fisher Scientific Gibco Culture for Bioprocessing
• WuXi AppTec